news aktuell GmbH

Roger Waters fights back

Share
Roger Waters defends freedom of speech and takes legal action against proposed concert cancellations in Frankfurt and Munich.

(London, United Kingdom): In February 2023, the Hessian State Government and then the Magistrate of the City of Frankfurt announced their extraordinary and prejudicial intention to cancel a concert scheduled to be performed by Roger Waters at the Festhalle in Frankfurt on 28 May. On 28 February 2023, a motion was introduced in the Munich City Council to cancel the concert scheduled for 21 May 2023, in the Munich Olympiahalle. These actions are unconstitutional, without justification, and based upon the false accusation that Roger Waters is antisemitic, which he is not. 

As a result of this unilateral, politically motivated action, Mr Waters has instructed his lawyers to immediately take all necessary steps to overturn this unjustifiable decision to ensure that his fundamental human right of freedom of speech is protected and that all of those who wish to see him perform, are free to do so in Frankfurt, Munich and in any other city in any other country. 

Mr Waters believes that if this blatant attempt to silence him is left unchallenged it could have serious, far-reaching consequences for artists and activists all over the world.

Publisher:
Mark Fenwick Management – London
on behalf of Mr George Roger Waters

Contacts

Press Contact:
HÖCKER Rechtsanwälte PartGmbB
Rechtsanwalt Prof. Dr. Ralf Höcker
Rechtsanwalt Michael Fengler
Friesenplatz 1
50672 Köln
Germany
E-Mail: contact@hoecker.eu
Tel: +49(0)221-93319-10
Fax: +49(0)221-93319-110

About news aktuell GmbH

news aktuell GmbH
news aktuell GmbH
Mittelweg 144
20148 Hamburg

+49 (0)40 4113-32589http://www.newsaktuell.de

news aktuell, a subsidiary of the Deutsche Presse-Agentur (dpa), provides companies, institutions and associations with effective access to both the media and consumers and supports the organizations in telling their stories easily and successfully. Utilizing the digital tools “ots” and “zimpel” PR content reaches all media formats, including classic print titles, wide-reach online portals or social networks. In addition, news aktuell publishes all of its clients' PR content on www.presseportal.de, one of Germany's widest-reaching PR portals. Thus, all relevant multipliers are reached worldwide, ranging from editors and digital influencers to specialist bloggers and interested consumers. Communications specialists from all over Germany rely on the expertise of the dpa subsidiary. news aktuell has been on the market since 1989 and employs over 135 people. The company is based in Hamburg. Further locations include Berlin, Frankfurt and Munich.

Subscribe to releases from news aktuell GmbH

Subscribe to all the latest releases from news aktuell GmbH by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from news aktuell GmbH

End-to-end digitalization in production: iTAC presents MOM system at HANNOVER MESSE24.3.2023 08:55:32 CET | Press release

The demands for agility and efficiency in manufacturing are increasing. Simultaneously, quality must be maintained at a high level. iTAC Software AG and its parent company Dürr have the answer: a modular all-in-one solution for the planning, execution, control, monitoring, optimization and predictive analysis of manufacturing. The Manufacturing Operations Management (MOM) system is based on end-to-end networking and digitalization. Another special feature is the microservices architecture to provide functionalities tailored to specific requirements. The company will be demonstrating the advantages of this solution at HANNOVER MESSE (hall15, booth E34).

Adragos Pharma acquires Clinigen’s development unit, Lamda Laboratories20.3.2023 09:43:28 CET | Press release

Acquisition strengthens Adragos end-to-end integrated service offering within the pharmaceutical product development segment Agreement includes further product development activities for Clinigen Limited Lamda spurs further growth for Adragos as its 3rd site in Europe, and 5th globally (Munich / London / Athens) – Munich-based pharmaceutical contract development organization (CDMO) Adragos Pharma GmbH has signed a definitive agreement with global pharmaceutical services company Clinigen Limitedto acquire Lamda Laboratories S.A. in Athens. The acquisition of Lamda Laboratories significantly expands Adragos' pharmaceutical product development, regulatory affairs and supply chain management services for its global pharmaceutical customers. Lamda has not only acted as Clinigen’s sole development center but has also established a well-earned reputation as a highly reliable contract development organization (CDO) for third party customers. Under a pharmaceutical development services agreemen

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom